Therapeutic peptides and oligonucleotides are rapidly growing product classes; however, novel modifications and formulations present new challenges for the products. Therefore, additional best practices and guidance are critically needed to expedite quality products coming to the global market.

USP will continue to support therapeutic peptides and oligonucleotides by gathering experts from the analytical, process development, and regulatory communities to share best practices and success stories.

The presentations and Panel discussions with experts across the globe will provide opportunities for attendees to ask questions and dig deeper into the presented content.